Do analysts rate ELUT or IRIX?

IRIDEX has a consensus target price of $3.00, indicating a potential upside of 347.76%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts plainly believe IRIDEX is more favorable than Elutia. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elutia 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation and earnings, ELUT or IRIX?

Elutia has higher earnings, but lower revenue than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elutia $12.29M 3.06 $53.38M $0.95 0.89 IRIDEX $52.67M 0.22 -$4.44M -$0.20 N/A

Is ELUT or IRIX more profitable?

Elutia has a net margin of 426.93% compared to IRIDEX's net margin of -6.88%. IRIDEX's return on equity of 0.00% beat Elutia's return on equity. Company Net Margins Return on Equity Return on Assets Elutia 426.93% -407.37% -47.08% IRIDEX -6.88% N/A -12.55%

Do analysts recommend QTI or IRIX?

IRIDEX has a consensus target price of $3.00, indicating a potential upside of 347.76%. Given IRIDEX's higher probable upside, analysts plainly believe IRIDEX is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation & earnings, QTI or IRIX?

IRIDEX has higher revenue and earnings than QT Imaging. IRIDEX is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio QT Imaging $18.92M 1.90 -$21.08M -$1.57 N/A IRIDEX $52.67M 0.22 -$4.44M -$0.20 N/A

Is QTI or IRIX more profitable?

IRIDEX has a net margin of -6.88% compared to QT Imaging's net margin of -77.25%. IRIDEX's return on equity of 0.00% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets QT Imaging -77.25% -1,202.69% -46.76% IRIDEX -6.88% N/A -12.55%

Is SNWV or IRIX more profitable?

Sanuwave Health has a net margin of 32.38% compared to IRIDEX's net margin of -6.88%. Sanuwave Health's return on equity of 1,728.10% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets Sanuwave Health 32.38% 1,728.10% 39.04% IRIDEX -6.88% N/A -12.55%

Which has stronger earnings & valuation, IRIX or NSPR?

IRIDEX has higher revenue and earnings than InspireMD. IRIDEX is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.22 -$4.44M -$0.20 N/A InspireMD $10.84M 3.29 -$19.92M -$0.64 N/A

Is IRIX or NSPR more profitable?

IRIDEX has a net margin of -6.88% compared to InspireMD's net margin of -413.96%. IRIDEX's return on equity of 0.00% beat InspireMD's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% InspireMD -413.96% -69.42% -57.68%

IRIDEX (IRIX) Competitors

$0.67 0.00 (0.00%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.66 -0.01 (-1.79%)

As of 04:34 AM Eastern

Compare

IRIX vs. MLSS, ELUT, QTI, SNWV, and NSPR

Should you buy IRIDEX stock or one of its competitors? IRIDEX's main competitors and comparable companies include Milestone Scientific (MLSS), Elutia (ELUT), QT Imaging (QTI), Sanuwave Health (SNWV), and InspireMD (NSPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does IRIDEX compare to Milestone Scientific?

IRIDEX (NASDAQ:IRIX) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

IRIDEX has a net margin of -6.88% compared to Milestone Scientific's net margin of -52.01%. IRIDEX's return on equity of 0.00% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Milestone Scientific	-52.01%	-60.26%	-40.23%

IRIDEX presently has a consensus price target of $3.00, suggesting a potential upside of 347.76%. Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 145.40%. Given IRIDEX's higher probable upside, research analysts clearly believe IRIDEX is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 9.2% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

IRIDEX has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.22	-$4.44M	-$0.20	N/A
Milestone Scientific	$9.42M	3.92	-$6.93M	-$0.04	N/A

In the previous week, Milestone Scientific had 2 more articles in the media than IRIDEX. MarketBeat recorded 2 mentions for Milestone Scientific and 0 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.21 beat Milestone Scientific's score of -0.51 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Neutral
Milestone Scientific	Negative

IRIDEX has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Summary

IRIDEX beats Milestone Scientific on 9 of the 15 factors compared between the two stocks.

How does IRIDEX compare to Elutia?

Elutia (NASDAQ:ELUT) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Elutia has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

74.0% of Elutia shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 17.8% of Elutia shares are owned by company insiders. Comparatively, 8.6% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Elutia has higher earnings, but lower revenue than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elutia	$12.29M	3.06	$53.38M	$0.95	0.89
IRIDEX	$52.67M	0.22	-$4.44M	-$0.20	N/A

Elutia has a net margin of 426.93% compared to IRIDEX's net margin of -6.88%. IRIDEX's return on equity of 0.00% beat Elutia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elutia	426.93%	-407.37%	-47.08%
IRIDEX	-6.88%	N/A	-12.55%

IRIDEX has a consensus target price of $3.00, indicating a potential upside of 347.76%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts plainly believe IRIDEX is more favorable than Elutia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elutia	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, IRIDEX's average media sentiment score of 0.21 beat Elutia's score of 0.00 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Elutia	Neutral
IRIDEX	Neutral

Summary

Elutia beats IRIDEX on 8 of the 15 factors compared between the two stocks.

How does IRIDEX compare to QT Imaging?

QT Imaging (NASDAQ:QTI) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

IRIDEX has a net margin of -6.88% compared to QT Imaging's net margin of -77.25%. IRIDEX's return on equity of 0.00% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-77.25%	-1,202.69%	-46.76%
IRIDEX	-6.88%	N/A	-12.55%

In the previous week, QT Imaging had 2 more articles in the media than IRIDEX. MarketBeat recorded 2 mentions for QT Imaging and 0 mentions for IRIDEX. QT Imaging's average media sentiment score of 1.83 beat IRIDEX's score of 0.21 indicating that QT Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
QT Imaging	Very Positive
IRIDEX	Neutral

IRIDEX has higher revenue and earnings than QT Imaging. IRIDEX is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92M	1.90	-$21.08M	-$1.57	N/A
IRIDEX	$52.67M	0.22	-$4.44M	-$0.20	N/A

IRIDEX has a consensus target price of $3.00, indicating a potential upside of 347.76%. Given IRIDEX's higher probable upside, analysts plainly believe IRIDEX is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 25.4% of QT Imaging shares are owned by company insiders. Comparatively, 8.6% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

IRIDEX beats QT Imaging on 7 of the 13 factors compared between the two stocks.

How does IRIDEX compare to Sanuwave Health?

Sanuwave Health (NASDAQ:SNWV) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

Sanuwave Health has a net margin of 32.38% compared to IRIDEX's net margin of -6.88%. Sanuwave Health's return on equity of 1,728.10% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
IRIDEX	-6.88%	N/A	-12.55%

In the previous week, Sanuwave Health had 1 more articles in the media than IRIDEX. MarketBeat recorded 1 mentions for Sanuwave Health and 0 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.21 beat Sanuwave Health's score of 0.00 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanuwave Health	Neutral
IRIDEX	Neutral

Sanuwave Health has higher earnings, but lower revenue than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	0.89	$11.81M	$0.24	18.96
IRIDEX	$52.67M	0.22	-$4.44M	-$0.20	N/A

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Comparatively, 8.6% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Sanuwave Health has a beta of 1.47, meaning that its share price is 47% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

Sanuwave Health presently has a consensus price target of $47.00, indicating a potential upside of 932.97%. IRIDEX has a consensus price target of $3.00, indicating a potential upside of 347.76%. Given Sanuwave Health's higher probable upside, equities research analysts plainly believe Sanuwave Health is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Sanuwave Health beats IRIDEX on 12 of the 15 factors compared between the two stocks.

How does IRIDEX compare to InspireMD?

IRIDEX (NASDAQ:IRIX) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

IRIDEX has higher revenue and earnings than InspireMD. IRIDEX is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.22	-$4.44M	-$0.20	N/A
InspireMD	$10.84M	3.29	-$19.92M	-$0.64	N/A

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 25.0% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

IRIDEX has a net margin of -6.88% compared to InspireMD's net margin of -413.96%. IRIDEX's return on equity of 0.00% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
InspireMD	-413.96%	-69.42%	-57.68%

In the previous week, IRIDEX's average media sentiment score of 0.21 beat InspireMD's score of 0.00 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Neutral
InspireMD	Neutral

IRIDEX presently has a consensus target price of $3.00, suggesting a potential upside of 347.76%. InspireMD has a consensus target price of $4.50, suggesting a potential upside of 486.40%. Given InspireMD's stronger consensus rating and higher possible upside, analysts plainly believe InspireMD is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

IRIDEX has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, InspireMD has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Summary

InspireMD beats IRIDEX on 8 of the 15 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRIX vs. The Competition

Export

Metric	IRIDEX	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$11.77M	$5.49B	$7.22B	$12.94B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-3.35	25.34	275.48	25.40
Price / Sales	0.22	72.80	653.49	82.06
Price / Cash	N/A	33.11	28.13	34.74
Price / Book	-11.17	5.90	10.57	6.32
Net Income	-$4.44M	$151.55M	$3.49B	$358.20M
7 Day Performance	4.69%	0.23%	-0.23%	0.42%
1 Month Performance	-11.39%	-3.83%	-2.67%	-3.30%
1 Year Performance	-43.70%	6.90%	18.17%	5.33%

IRIDEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRIX IRIDEX	1.6286 of 5 stars	$0.67 flat	$3.00 +347.8%	-43.7%	$11.77M	$52.67M	N/A	108	Analyst Downgrade Gap Down
MLSS Milestone Scientific	1.4878 of 5 stars	$0.42 +3.7%	$1.00 +141.0%	-21.4%	$37.62M	$9.42M	N/A	30	Gap Up
ELUT Elutia	1.1812 of 5 stars	$0.82 +2.5%	N/A	-22.0%	$36.32M	$12.29M	0.86	180	Gap Up
QTI QT Imaging	1.1749 of 5 stars	$2.57 +0.4%	N/A	+1.0%	$35.82M	$18.92M	N/A	N/A	Positive News
SNWV Sanuwave Health	2.0836 of 5 stars	$4.17 +1.5%	$47.00 +1,027.1%	-87.0%	$35.81M	$44.05M	17.35	40	News Coverage Analyst Downgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRIX) was last updated on 9/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Competitors

IRIX vs. MLSS, ELUT, QTI, SNWV, and NSPR

How does IRIDEX compare to Milestone Scientific?

Summary

How does IRIDEX compare to Elutia?

Summary

How does IRIDEX compare to QT Imaging?

Summary

How does IRIDEX compare to Sanuwave Health?

Summary

How does IRIDEX compare to InspireMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IRIDEX (IRIX) Competitors

IRIX vs. MLSS, ELUT, QTI, SNWV, and NSPR

How does IRIDEX compare to Milestone Scientific?

Is IRIX or MLSS more profitable?

Do analysts rate IRIX or MLSS?

Do institutionals & insiders believe in IRIX or MLSS?

Which has better earnings and valuation, IRIX or MLSS?

Does the media prefer IRIX or MLSS?

Which has more risk and volatility, IRIX or MLSS?

Summary

How does IRIDEX compare to Elutia?

Which has more volatility & risk, ELUT or IRIX?

Do institutionals & insiders have more ownership in ELUT or IRIX?

Which has stronger valuation and earnings, ELUT or IRIX?

Is ELUT or IRIX more profitable?

Do analysts rate ELUT or IRIX?

Does the media favor ELUT or IRIX?

Summary

How does IRIDEX compare to QT Imaging?

Is QTI or IRIX more profitable?

Does the media prefer QTI or IRIX?

Which has higher valuation & earnings, QTI or IRIX?

Do analysts recommend QTI or IRIX?

Do insiders and institutionals have more ownership in QTI or IRIX?

Summary

How does IRIDEX compare to Sanuwave Health?

Is SNWV or IRIX more profitable?

Does the media favor SNWV or IRIX?

Which has preferable earnings & valuation, SNWV or IRIX?

Do institutionals & insiders have more ownership in SNWV or IRIX?

Which has more risk & volatility, SNWV or IRIX?

Do analysts prefer SNWV or IRIX?

Summary

How does IRIDEX compare to InspireMD?

Which has stronger earnings & valuation, IRIX or NSPR?

Do institutionals and insiders have more ownership in IRIX or NSPR?

Is IRIX or NSPR more profitable?

Does the media refer more to IRIX or NSPR?

Do analysts recommend IRIX or NSPR?

Which has more volatility and risk, IRIX or NSPR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools